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INTRODUCTION 
The synthesis of new structures with the predicted 
activity is expedient to carry out in that class of chemical 
compounds where substances with a certain directed 
action have been already found (Oliveira et al., 2019). 
Scientists refer the heterocyclic system of 1,2,4-triazole to 
the privileged structure (“privileged scaffold”), since 
most of the derivatives of this heterocyclic synthesized 
exhibit some pharmacological activity, including the 
antiinflammatory (Zhuang et al., 2017). The combination 
of factors affecting biochemical processes, as well as the 
practical absence of toxic effects on the body, indicates the 
feasibility of further targeted search for new biologically 
active substances among derivatives of 1,2,4-triazole 
(Mioc et al., 2017). A careful study of the literature data on 
the spectrum of pharmacological properties of the 
heterocyclic system of 1,2,4-triazole allows us to 
confidently assert that the presence of this cycle in the 
structure of substances determines the manifestation of 
the antiinflammatory activity (Moise et al., 2009). 
Previous research by Sondhi et al. (2007) obtained a large 
group of derivatives of 1,2,4-triazole, pyridine, pyrrol, 
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 Abstract 
The strategy of rational approaches to the search for selective COX-2 
inhibitors as potential antiinflammatory agents has been proposed and 
elaborated. It is based on the use of PASS-prediction and molecular 
docking. The choice of the basic structure of 4-amino-3-thio-1,2,4-
triazole as a promising object of chemical modification has been 
substantiated. Using a modification of the primary molecule, a virtual 
library of S-derivatives of 5-substituted 4-amino(pyrrol)3-thio-4H-
1,2,4-triazoles in the amount of 100 compounds (ten groups) has been 
obtained by introducing various pharmacophore fragments. Based on 
the analysis of the results of the PASS-prediction and molecular 
docking, six of the ten planned groups of compounds have been 
selected for the synthesis as promising selective COX-2 inhibitors. The 
reliability of the prediction results has already been confirmed for one 
of the promising group 4-amino-5-(pyridine-4-yl)-1,2,4-triazole (4Н)-
3-yl-thioacetamides. 
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and other related heterocyclic compounds, among them 
selective cyclooxygenase-2 (COX-2), 5-lipoxygenase (5-
LOX), and COX-2/5-LOX double inhibitors were 
identified. Moreover, some studies suggest that the 
presence of the 1,2,4-triazole cycle causes selective 
inhibition of COX-2 (Cai et al., 2015; Jiang et al., 2010). 
In addition, 1,2,4-triazole derivatives are low-toxic, rather 
simple in synthesis and highly reactive substances. It 
allows to introduce various pharmacophore fragments 
into their structure (Khanage et al., 2012). Our analysis of 
the scientific literature has shown that despite a large 
number of publications devoted to functional derivatives 
of 1,2,4-triazole the pharmacological potential of this class 
of compounds at the present stage is not exhausted.  
The compound of 4-amino-3-thio-1,2,4-triazole has a 
high synthetic potential, significant opportunities in 
terms of the introduction of pharmacophore fragments 
and, correspondingly, the expansion of the spectrum for 
searching the biological activity. The presence of a sulfur 
atom in the basic structure increases lipophilicity and, 
therefore, can improve absorption and bioavailability of 
the compounds synthesized on its basis (Jin et al., 2007). 
In addition, thio and amino groups are reaction centers 
for the introduction of additional pharmacophores into 
the molecule. 
 
MATERIALS AND METHODS 
The introduction of different pharmacophore fragments 
into the molecule by modifying the thio group and 
obtaining S-derivatives of 5-substituted 4-
amino(pyrrol)3-thio-4H-1,2,4-triazoles (groups of 
compounds I-X). This allows increasing the chances of 
finding new effective compounds in this series, as 
presented in Figure 1. The following modification have 
been planned as follows: 
1. Alkylation of 5-pyridine-4-amino(pyrrol)3-thio-1,2,4- 
triazole derivatives by haloalkanes (1-bromopropane, 
1-bromohexane, 1-bromoheptan, 1-bromononane, 1-
bromodecane) (I) in order to increase lipophilicity of 
the initial 5-pyridine-4-yl-4-amino-3-thio-4Н-1,2,4-
triazole. 
2. Introduction of the arylidene aniline fragment (II) to 
alkyl derivatives of group (I), it will increase the 
number of unsaturated bonds in the molecule and 
may increase the activity. 
3. Oxidation of 5-(pyridine-4)-4-amino-3-thio-1,2,4-
triazole derivatives to alkyl sulfonyl derivatives (III) 
as in the structure of modern oxicams there is a 
sulfonyl group. 
4. Introduction of the 5-(pyridine-4)-4-amino-3-thio-
1,2,4-triazole fragment of alkyl urea (IV) into the basic 
structure since there are literature data concerning the 
effect of the acetamide residue the increase of the 
antiinflammatory activity. 
5. Alkylation of 5-(pyridine-4(2,3))-4-amino-3-thio-1,2,4-
triazoles (V-VI) by α-chloroacetamide’s taking into 
account the literature data concerning the effect of the 
acetamide residue on the increase of the 
antiinflammatory activity. 
6. Alkylation of 5-(furyl-2)-amino-3-thio-1,2,4-triazoles 
(VII) by α-chloroacetamide’s. 
7. Replacement of the amino group in S-alkyl 
derivatives of 5-(pyridine-2,4)-4-amino-3-thio-4Н-
1,2,4-triazoles (VIII-IX) and 5-(furyl-2)-4-amino-3-
thio-4Н-1,2,4-triazoles (X) on the pyrrol residue. 
 
I 
 
 
II 
Borneo Journal of Pharmacy, Vol 3 Issue 1, February 2020, Page 36 – 43  e-ISSN: 2621-4814 
38 
 
III 
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X=N, Y=C X=C, Y=N 
V 
 
 
VI 
 
 
VII 
 
 
VIII 
 
 
IX 
 
 
X 
 
Figure 1. General formulas for the planned groups of new 
structures of 5-substituted 4-amino(pyrrol)3-thio-4H-1,2,4-
triazoles from compounds I to X 
 
A more real possibility of a comprehensive study of the 
biological activity of substances is the use of new 
computer prediction technologies in silico and their 
application to the assessment of the spectrum of activity 
of chemical compounds with subsequent testing of the 
substances studied according to the results of the 
prediction (Parasuraman, 2011). We have proposed a 
methodology for assessing the activity using the existing 
calculation programs. 
The logical and structural assessment of the possible 
biological effect was performed using the Prediction of 
Activity Spectra for Substances (PASS) computer system 
online (http://www.pharmaexpert.ru/PassOnline). 
This system predicts 565 types of the biological activity by 
the structural formula of the chemical compound. These 
activities include the main and side pharmacological 
effects, mechanisms of their implementation and toxic 
manifestations, such as mutagenicity, carcinogenicity 
and teratogenicity (Lagunin et al., 2000). 
The prediction result is presented in the form of 
confidence “to be active” – Pa and “to be inactive” – Pi by 
the types of activity. It should be noted that the data 
obtained using the PASS program can serve only as an 
indicative characteristic when selecting promising 
molecules and help to conduct the primary sample of 
probable promising groups. It is known that the Pa value 
reflects, first of all, the similarity of the molecule with the 
most typical known drugs of the training sample (Assyl 
et al., 2014). 
In order to optimize the targeted search for COX-2 
inhibitors as potential antiinflammatory agents and 
substantiate the feasibility of the experimental screening 
for the antiinflammatory activity the docking studies 
were also conducted (Laube et al., 2016). Conducting the 
docking studies has allowed us to investigate the affinity 
of a definite group of compounds to this biological target, 
predict the ability of substances to inhibit the catalytic 
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activity of 1СХ2 and 6СОХ, i.e. to identify their inhibitor, 
which is a key link in the pathogenesis of the disease. The 
use of in silico methods also makes it possible to save 
laboratory animals in the case of complete absence of 
affinity to potential biological targets (Leelananda & 
Lindert, 2016). 
Method 
Generation of the 3D-structure of the planned substances and 
their optimization using the method of molecular mechanics 
MM+ and semi-empirical quantum mechanical method PM3 
Objects of this study were derivatives of 4-amino-5-
(pyridine-2(3)-yl)-1,2,4-triazole(4Н)-3-yl-thioacetamides; 
4-amino-5-(pyridine-4-yl)-1,2,4-triazole(4H)-3-yl-
thioacetamides; and their pyrrol derivatives of 2-((4-
amino-5-(furan-2-yl)-1,2,4-triazole(4h)-3-yl)-sulfonyl)-N-
acetamides and their pyrrol derivatives, as well as the 
known selective COX-2 inhibitors (celecoxib, natrium 
diclofenac) and non-selective inhibitor aspirin. 
The choice of antiinflammatory biological targets and 
determination of their active sites 
Crystallographic models of COX-2 was obtained from 
Protein Data Bank (www.rcsb.org), with PDB ID 6COX 
and PDB ID 1СХ2 (Kurumbail et al., 1997). Their 
difference lies in the different spatial groups of ligand 
binding. In both crystallographic models of COX-2 PDB 
ID 1СХ2 (chains A, B, C, D) and PDB ID 6COX (chains A, 
B) the following ligands were isolated: selective COX-2 
inhibitor SC-558, protoporphyrin IX (contains Fe), N-
acetyl-D-glucosamine in accordance with the literature 
data that 1СХ2 and 6COX crystallographic models 
represent such spatial groups as P 21 21 2 and I 2 2 2. 
(Kurumbail et al., 1997). These data indicate the difference 
in protein conformations, and, therefore, the structural 
difference of the binding regions; it affects the protein-
ligand interactions. Thus, we considered it expedient to 
take into account the data obtained as a result of the use 
of both crystallographic forms of COX-2 in the docking 
studies. After addition hydrogen atoms to 1СХ2 and 
6СОХ molecules, removal of water molecules, and 
isolation of chains B, C, D and B, respectively, the active 
sites of proteins 1CX2 were isolated as presented in 
Figure 2. 
 
Figure 2. The active site of 1СХ2 protein 
 
Conducting the actual molecular docking 
The docking studies of hypothetical compounds were 
conducted using a SCIGRESS software package (Fujitsu, 
Fukuoka, Japan with license 742F6852C191). The 
parameter used is binding free energy (kcal/mol), where 
the value of binding free energy of all test compounds is 
compared with comparative compounds such as 
celecoxib, aspirin, and natrium diclofenac. The genetic 
algorithm, an evolutionary search algorithm applied to 
solve optimization and modeling problems by sequential 
selection, combination and variation of the parameters 
studied was used for automatic docking. The use of the 
genetic algorithm makes it possible to effectively study 
the entire available space for the ligand (Torres et al., 
2019). 
 
RESULTS AND DISCUSSION 
According to the prediction results the probability of 
detection of the antiinflammatory activity in the group of 
S-alkyl derivatives of 5-(pyridine-4-yl)-3-thio-4-amino-
4Н-1,2,4-triazole (I) is insignificant, the average value of 
Ра does not exceed 0.39 for the antiinflammatory activity 
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and 0.32 for the analgesic activity. After replacing the 
amino group in position 4 of the 1,2,4-triazole cycle on the 
substituted benzylidene fragment an insignificant 
increase in the antiinflammatory and analgesic activity of 
compounds in group II is predicted. After this 
modification the highest probability of detection of the 
antiinflammatory activity is predicted for 4-methoxy, 4-
nitro, and 4-butylphenyl derivatives; however, for these 
compounds, the Ра value does not exceed 0.4 for the 
antiinflammatory activity and 0.49 for the analgesic 
activity. The average value of Ра ≤ 0.500, hence, the group 
is not promising for the synthesis. 
Despite the fact that the presence of a sulfonyl group can 
increase the antiinflammatory activity, which has been 
proven in modern COX inhibitors including piroxicam, 
tenoxicam, celecoxib, etc. (Cordero et al., 2001), the 
probability of its manifestation is insignificant according 
to the results of the computer prediction for sulfonyl 
derivatives of 5-(pyridine-4-yl)-3-thio-4-amino-4Н-1,2,4-
triazole (III). The Ра value does not exceed 0.35, in 
addition, there is a clear regularity: with an increase in the 
number of carbon atoms in alkyl radicals, the Ра value 
decreases and, therefore, there is the probability of 
detecting the antiinflammatory activity. Therefore, 
compounds I to III were not tested by molecular 
docking. 
With a low degree of probability (Ра ≤ 0.3), the 
manifestation of the antiinflammatory activity for group 
IV of thiourea derivatives of 4-amino-3-thio-5-(pyridine-
4-yl)-1,2,4-triazole(4Н) is predicted. According to the data 
of the PASS computer program online, the 
antiinflammatory and analgesic activities are predicted 
for those groups of compounds that contain the pyridine 
cycle in position 5 (the activity indices are in the range 
from 0.51 to 0.66). 
By the computer prediction data, 4-amino-5-(pyridine-
2(3)-yl)-1,2,4-triazole(4Н)-3-yl-thioacetamides (group V) 
are promising compounds. Further chemical 
modification by moving the nitrogen atom to the para-
position of the pyridine cycle in 4-amino-5-(pyridine-4-
yl)-1,2,4-triazole(4H)-3-yl-thioacetamides – the structure 
of general formula from group VI, and the introduction 
of the furyl fragment (group VII) were highly 
appropriate. For compounds in group VII, the indices of 
the antiinflammatory activity are the highest among all 
planned groups (0.63-0.65). But for compounds of these 
groups the indices of the analgesic activity do not 
significantly decrease and are in the range from 0.58 to 
0.59. 
Another variant of the expedient optimization was the 
chemical modification of the amino group in position 4. 
The analysis of the computer prediction data obtained for 
S-alkyl derivatives, in which the amino group in 5-
(pyridine-2,4)-4-amino 3-thio-4Н-1,2,4-triazoles (VIII-IX) 
and 5-(furyl-2)-4-amino 3-thio-4Н-1,2,4-triazoles (X) was 
replaced by a pyrrol residue showed that the greatest 
probability of activity was also at the level of 
approximately 60%. 
Thus, according to the results of the in siliсo studies 
among ten planned groups of S-derivatives of 5-(R)-4-
amino-3-thio-4H-1,2,4-triazole (groups of compounds I-
X), only six groups that are likely to be antagonists of 
prostaglandins, and can exhibit antiexudative and 
analgesic effects have been selected as promising 
compounds (Chalenko & Syrovaya, 2017). 
The docking studies of the sample for derivatives of 4-
amino-5-(pyridine-2(3)-yl)-1,2,4-triazole(4Н)-3-yl-
thioacetamides, 4-amino-5-(pyridine-4-yl)-1,2,4-triazole 
(4Н)-3-yl-thioacetamides and their pyrrol derivatives, 2-
((4-amino-5-(furan-2-yl)-1,2,4-triazole(4Н)-3-yl)-
sulfonyl)-N-acetamides and their pyrrol derivatives were 
conducted by the method of a flexible molecular docking 
into the active zone of the COX-2 enzyme (Mozziconacci 
et al., 2005). As a result of the docking studies the value of 
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Consensus scoring functions, which assess certain 
characteristics of the ligand-protein complex and indicate 
the possibility of their comparison, has been obtained. 
Consensus functions allow forming a rating of 
compounds according to the values of all scoring 
functions and analyzing data on the choice of potential 
agonists/antagonists of the biological target selected 
(Sliwoski et al., 2014). The average values of the calculated 
scoring functions of molecular docking for promising 
groups of compounds are given in Table I. 
Table I. The values of scoring functions for promising 
groups of compounds and reference drugs 
obtained when conducting molecular docking 
Compounds 
Binding free energy (kcal/mol) 
1CX2 6COX 
Celecoxib -99.81 -109.3 
Aspirin -77.7 -79.6 
Natrium diclofenac -70.3 -70.4 
IV -61.1 to -67.6 -61.4 to -66.5 
V -91.1 to -97.6 -91.1 to -97.6 
VI -108.1 to -122.7 -108.1 to -122.7 
VII -98.8 to -107.67 -98.8 to -107.67 
VIII -90.14 to -101.2 -90.14 to -101.2 
IX -93.17 to -100.7 -90.25 to -101.0 
X -87.14 to -91.2 -87.14 to -91.2 
 
The values of scoring functions for almost all compounds 
in complexes with the COX-2 enzyme exceed the values 
of these functions for aspirin and natrium diclofenac. For 
group VI the average values of scoring functions for 
binding free energy exceed the values for celecoxib. 
Visualization of docking results for the most promising 
compound of group VI is presented in Figure 3. 
 
Figure 3. The promising compound in the protein active site 
(1СХ2 crystallographic model) 
 
The data obtained are an argument for studying the 
antiinflammatory activity for all six groups of 
compounds selected. Based on these data it has been 
determined that 4-amino-5-(pyridine-4-yl)-1,2,4-
triazole(4Н)-3-yl-thioacetamides and their pyrrol 
derivatives are characterized by the highest level of 
affinity calculated to all targets studied compared with 
other groups of compounds. Their affinity value is 
comparable to classical agonists, and it opens the 
opportunity of identifying new receptor agonists. The 
reliability of the prediction results has already been 
confirmed for one of the promising groups 4-amino-5-
(pyridine-4-yl)-1,2,4-triazole(4Н)-3-yl-thioacetamides. 
The planned substances have been synthesized and 
tested for antiinflammatory activity, besides it has also 
been published scientifically (Chalenko et al., 2019). 
 
CONCLUSION 
In order to search for potential antiinflammatory agents 
1,2,4-triazol-3-thiones have been selected as promising 
objects of chemical modification. The strategy of rational 
approaches to the search for selective COX-2 inhibitors as 
potential antiinflammatory agents has been proposed 
and elaborated. It is based on the use of the PASS-
prediction and molecular docking. Based on the results of 
the PASS-prediction and molecular docking, six of the 
ten planned groups of compounds have been selected for 
the synthesis as promising selective COX-2 inhibitors. 
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